[Combination chemotherapy of acute myeloblastic leukemias (author's transl)].
D000293:Adolescent; D000328:Adult; D000380:Agranulocytosis / Q000139:chemically induced; D001792:Blood Platelets; D001803:Blood Transfusion; D002228:Carbenicillin / Q000627:therapeutic use; D002512:Cephalothin / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use*; D003561:Cytarabine / Q000009:adverse effects / Q000627:therapeutic use*; D003630:Daunorubicin / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D012075:Remission, Spontaneous; D014839:Vomiting / Q000139:chemically induced
D005839:Gentamicins; D003561:Cytarabine; D003520:Cyclophosphamide; D002228:Carbenicillin; D002512:Cephalothin; D011241:Prednisone; D003630:Daunorubicin
La polychimiothérapie des leucémies aiguës myéloblastiques